Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.56%14.3614.2%$227.60m
SHPGShire PLC Sponsored ADR
1.64%143.160.4%$216.15m
PRGOPerrigo Co. Plc
1.30%78.596.4%$152.47m
MNKMallinckrodt Plc
2.77%37.1317.7%$118.19m
UTHRUnited Therapeutics Corporation
1.13%131.2813.9%$88.16m
JAZZJazz Pharmaceuticals Plc
2.89%146.742.2%$81.28m
ENDPEndo International Plc
-1.64%8.388.9%$71.09m
HZNPHorizon Pharma plc
-0.34%13.137.6%$65.29m
ALRAlere Inc.
0.22%49.552.7%$64.57m
PRXLPAREXEL International Corporation
0.07%87.737.9%$63.41m
ICPTIntercept Pharmaceuticals, Inc.
2.31%107.0922.1%$62.54m
MYOKMyoKardia, Inc.
1.27%43.803.0%$53.28m
NDRMNeuroDerm Ltd.
-0.13%38.603.6%$51.57m
PTLAPortola Pharmaceuticals, Inc.
0.70%55.958.9%$42.76m
ICLRICON Plc
2.46%107.894.2%$41.33m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.